Popescu, B., Jones, M. F., Piao, M., Tran, E., Koh, A., Lomeli, I., Peretz, C. A. C., Murad, N., Abelson, S., Morales, C., Rivera, J. M., Batingana, A. R., D’Souza, J., Pikman, Y., Cheng, M. L., Logan, A. C., Huang, B. J., Stieglitz, E., Smith, C. C. (2026). Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML. Blood. https://doi.org/10.1182/blood.2025030558